Product Information
MOVANTIK 12.5 MG TABLET is a brand product labeled by Valinor Pharma, LLC, priced at $14.5987 per EA under NDC 82625880101. Its NADAC has been published 159 times since Sep 20, 2023.
FDA first approved this application on Sep 16, 2014.
Strength
12.5 mg/1
Manufacturer
Valinor Pharma, LLCNDC
82625880101
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NALOXEGOL OXALATEApproval Type
New Drug (NDA)
FDA Application
NDA204760FDA Approved
9/16/2014
On Market Since
3/28/2023
Pharmacological Classes
Price Statistics
The NADAC for MOVANTIK 12.5 MG TABLET has been published 159 times since Sep 20, 2023, and over the history we have for it it has risen 15.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.5987 per EA |
|---|---|
| All-time high | $14.6092 (Aug 12, 2026) |
| All-time low | $12.6338 (Dec 20, 2023) |
| 52-week high | $14.6092 |
| 52-week low | $13.9064 |
| Median price | $13.9186 |
| Average price | $13.7523 |
| Largest weekly change | +5.0% (Jan 14, 2026) |
| Weeks tracked | 159 |
| Tracking since | Sep 20, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the naloxegol oxalate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Valinor Pharma, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
naloxegol oxalate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MOVANTIK 12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MOVANTIK 12.5 MG TABLET, manufactured by Valinor Pharma, LLC, is $14.5987 per EA (NDC 82625880101), effective Sep 30, 2026.
How has the price of MOVANTIK 12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MOVANTIK 12.5 MG TABLET has risen 15.5%. It has been tracked across 159 weekly CMS publications since Sep 20, 2023.
What are the highest and lowest recorded NADAC prices for MOVANTIK 12.5 MG TABLET?
Since Sep 20, 2023, the NADAC for MOVANTIK 12.5 MG TABLET has ranged from a low of $12.6338 (Dec 20, 2023) to a high of $14.6092 (Aug 12, 2026), with a median of $13.9186 per EA.
Are there cheaper alternatives to MOVANTIK 12.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of MOVANTIK 12.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MOVANTIK 12.5 MG TABLET?
MOVANTIK 12.5 MG TABLET (NDC 82625880101) is labeled by Valinor Pharma, LLC, and CMS classifies it as a brand product.